Page 21 - CIJ Feb 2025 - Digital Edition
P. 21
COVER STORY
Poor IAQ leads to discomfort,
reduced focus, air pollution, and
increased HVAC maintenance costs.
While biological contamination
lead to product recalls, regulatory
penalties and patient harm.”
– Vishwas Bhatnagar
“These pose serious risks in Regarding airborne particulate containment systems, and maintain
pharma, leading to product recalls, matter (PM), Cadila employs HVAC systems for optimal
regulatory penalties, and patient multiple controls. “We install HEPA performance,” he stated.
harm. Workers face respiratory filters, adhere to ISO 14644-1 Poor IAQ impacts employee
issues and allergic reactions. Strict classifications, conduct frequent air health and productivity. “Respiratory
monitoring, air filtration, and sampling, ensure proper airflow, problems, fatigue, dizziness, and
cleanroom protocols are essential.” enforce protective gear usage, use headaches are common. Low IAQ
reduces mental clarity, increases
sick leave, and lowers productivity.
Long-term exposure leads to chronic
issues, affecting both employees
and business operations,” Bhatnagar
concluded.
The consequences of inadequate
IAQ — from product recalls
to regulatory non-compliance
and worker health risks — are
severe. Cadila’s proactive IAQ
management, including adherence
to global standards and rigorous
monitoring, exemplifies best
practices.
For pharmaceutical companies,
robust IAQ management is not just
regulatory compliance but a vital
investment in product integrity,
employee well-being, operational
efficiency, and business continuity.
Neglecting IAQ is a risk no
manufacturer can afford.
21
www.cleanindiajournal.com•Clean India Journal•FEBRUARY 2025
